Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Lockhart

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medecine Sciences : M/S|May 5, 2009
[Biomarkers: "Found in translation"]Brian P Lockhart, Bernard Walther
Experimental Gerontology|January 25, 2003
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?Brian P Lockhart, Pierre J Lestage
Thrombosis Research|June 23, 2009
Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cellsAmandine Jaulmes, Patricia Sansilvestri-Morel, Gaëlle Rolland-Valognes, et al.
Science Signaling|December 10, 2009
Only a subset of Met-activated pathways are required to sustain oncogene addictionAndrea Bertotti, Mike F Burbridge, Stefania Gastaldi, et al.
Science Signaling|December 31, 2009
Only a subset of Met-activated pathways are required to sustain oncogene addictionAndrea Bertotti, Mike F Burbridge, Stefania Gastaldi, et al.
Journal of Hepatology|February 23, 2011
Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodellingMathieu Bergé, David Allanic, Philippe Bonnin, et al.
Molecular Cancer Therapeutics|June 28, 2013
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumabMike F Burbridge, Céline J Bossard, Carine Saunier, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 25, 2011
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA)Benjamin Di Cara, Roberto Maggio, Gabriella Aloisi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medecine Sciences : M/S|May 5, 2009
[Biomarkers: "Found in translation"]Brian P Lockhart, Bernard Walther
Experimental Gerontology|January 25, 2003
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?Brian P Lockhart, Pierre J Lestage
Thrombosis Research|June 23, 2009
Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cellsAmandine Jaulmes, Patricia Sansilvestri-Morel, Gaëlle Rolland-Valognes, et al.
Science Signaling|December 10, 2009
Only a subset of Met-activated pathways are required to sustain oncogene addictionAndrea Bertotti, Mike F Burbridge, Stefania Gastaldi, et al.
Science Signaling|December 31, 2009
Only a subset of Met-activated pathways are required to sustain oncogene addictionAndrea Bertotti, Mike F Burbridge, Stefania Gastaldi, et al.
Journal of Hepatology|February 23, 2011
Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodellingMathieu Bergé, David Allanic, Philippe Bonnin, et al.
Molecular Cancer Therapeutics|June 28, 2013
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumabMike F Burbridge, Céline J Bossard, Carine Saunier, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 25, 2011
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA)Benjamin Di Cara, Roberto Maggio, Gabriella Aloisi, et al.
Pageof 1